SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The primate lentivirus auxiliary protein Vpx counteracts an unknown restriction factor that renders human dendritic and myeloid cells largely refractory to HIV-1 infection. Here we identify SAMHD1 as this restriction factor. SAMHD1 is a protein involved in Aicardi-Goutières syndrome, a genetic encephalopathy with symptoms mimicking congenital viral infection, that has been proposed to act as a negative regulator of the interferon response. We show that Vpx induces proteasomal degradation of SAMHD1. Silencing of SAMHD1 in non-permissive cell lines alleviates HIV-1 restriction and is associated with a significant accumulation of viral DNA in infected cells. Concurrently, overexpression of SAMHD1 in sensitive cells inhibits HIV-1 infection. The putative phosphohydrolase activity of SAMHD1 is probably required for HIV-1 restriction. Vpx-mediated relief of restriction is abolished in SAMHD1-negative cells. Finally, silencing of SAMHD1 markedly increases the susceptibility of monocytic-derived dendritic cells to infection. Our results demonstrate that SAMHD1 is an antiretroviral protein expressed in cells of the myeloid lineage that inhibits an early step of the viral life cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, sterile alpha motif and HD domain 1 (SAMHD1) inhibits reverse transcription by depleting the cellular pool of deoxynucleotide triphosphates [63,64]”
From HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This approach was necessary because PU.1 is the master transcriptional regulator necessary for macrophage differentiation and silencing PU.1 prior to infection results in a change in the cellular phenotype that causes resistance to HIV infection72,73.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Rice, G. I., Bond, J., Asipu, A., Brunette, R. L., Manfield, I. W., Carr, I. M., Fuller, J. C., Jackson, R. M., Lamb, T., Briggs, T. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.373 · Cited by 689
A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells
Manel, N., Hogstad, B., Wang, Y., Levy, D. E., Unutmaz, D., & Littman, D. R. (2010) · Nature · doi:10.1038/nature09337 · Cited by 427
Sobhian, B., Laguette, N., Yatim, A., Nakamura, M., Levy, Y., Kiernan, R., & Benkirane, M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.04.012 · Cited by 381
Self-citationBlanchet, F. P., Moris, A., Nikolic, D. S., Lehmann, M., Cardinaud, S., Stalder, R., Garcia, E., Dinkins, C., Leuba, F., Wu, L., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.04.011 · Cited by 295
Self-citationImmunoaffinity Purification of Mammalian Protein Complexes
Nakatani, Y., & Ogryzko, V. (2003) · Methods in Enzymology · doi:10.1016/s0076-6879(03)70037-8 · Cited by 283
DCs and NK cells: critical effectors in the immune response to HIV-1
Altfeld, M., Fadda, L., Frleta, D., & Bhardwaj, N. (2011) · Nature Reviews Immunology · doi:10.1038/nri2935 · Cited by 216
Srivastava, S., Swanson, S. K., Manel, N., Florens, L., Washburn, M. P., & Skowronski, J. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000059 · Cited by 209
Cited by
Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection
Doitsh, G., Galloway, N. L. K., Geng, X., Yang, Z., Monroe, K. M., Zepeda, O., Hunt, P. W., Hatano, H., Sowinski, S., Muñoz-Arias, I., et al. (2014) · Nature · doi:10.1038/nature12940 · Cited by 1,179
Aicardi–Goutières syndrome and the type I interferonopathies
Crow, Y. J., & Manel, N. (2015) · Nature Reviews Immunology · doi:10.1038/nri3850 · Cited by 925
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923
HIV infection: epidemiology, pathogenesis, treatment, and prevention
Maartens, G., Celum, C., & Lewin, S. R. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60164-1 · Cited by 830
HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase
Goldstone, D. C., Ennis-Adeniran, V., Hedden, J. J., Groom, H. C. T., Rice, G. I., Christodoulou, E., Walker, P. A., Kelly, G., Haire, L. F., Yap, M. W., et al. (2011) · Nature · doi:10.1038/nature10623 · Cited by 831
Lahouassa, H., Daddacha, W., Hofmann, H., Ayinde, D., Logue, E. C., Dragin, L., Bloch, N., Maudet, C., Bertrand, M., Gramberg, T., et al. (2012) · Nature Immunology · doi:10.1038/ni.2236 · Cited by 852
Self-citationDeeks, S. G., Overbaugh, J., Phillips, A., & Buchbinder, S. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.35 · Cited by 644
Maalej, K. M., Merhi, M., Inchakalody, V. P., Mestiri, S., Alam, M., Maccalli, C., Cherif, H., Uddin, S., Steinhoff, M., Marincola, F. M., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01723-z · Cited by 618
“In fact, Vpx, can mediate degradation of SAM domain and HD domain-containing protein 1 (SAMHD1); a myeloid-specific HIV-1 restriction factor that inhibits lentiviral transduction [232].”
BackgroundSAMHD1 restricts HIV-1 infection in resting CD4+ T cells
Baldauf, H.-M., Pan, X., Erikson, E., Schmidt, S., Daddacha, W., Burggraf, M., Schenkova, K., Ambiel, I., Wabnitz, G., Gramberg, T., et al. (2012) · Nature Medicine · doi:10.1038/nm.2964 · Cited by 597
Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection
Goujon, C., Moncorgé, O., Bauby, H., Doyle, T., Ward, C. C., Schaller, T., Hué, S., Barclay, W. S., Schulz, R., & Malim, M. H. (2013) · Nature · doi:10.1038/nature12542 · Cited by 583
Interferon-inducible effector mechanisms in cell-autonomous immunity
MacMicking, J. D. (2012) · Nature Reviews Immunology · doi:10.1038/nri3210 · Cited by 579
Yan, N., & Chen, Z. J. (2012) · Nature Immunology · doi:10.1038/ni.2229 · Cited by 532
“80, 9754–9760 (2006). COMPETING FINANCIAL INTERESTS The authors declare no competing financial interests.”
BackgroundHIV Restriction Factors and Mechanisms of Evasion
Malim, M. H., & Bieniasz, P. D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006940 · Cited by 487
“Indeed, two groups very recently reported using proteomic methods to identify SAMHD1 (sterile a motif domain-, HD domain-containing protein 1) as the myeloid-specific, degradable cellular target of HIV-2/SIVsm Vpx proteins (Hrecka et al. 2011; Laguette et al. 2011).”
BackgroundRules of engagement: molecular insights from host–virus arms races
Daugherty, M. D., & Malik, H. S. (2012) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155522 · Cited by 515
Pestal, K., Funk, C. C., Snyder, J. M., Price, N. D., Treuting, P. M., & Stetson, D. B. (2015) · Immunity · doi:10.1016/j.immuni.2015.11.001 · Cited by 513
“Similarly, SAMHD1 is a dNTP phosphohydrolase that prevents cDNA synthesis by retroviral reverse transcriptase enzymes, strongly suggesting that the cGAS-STING pathway also drives autoimmunity in AGS caused by SAMHD1 mutations (Goldstone et al., 2011; Hrecka et al., 2011; Laguette et al., 2011; Rehwinkel et al., 2013).”
BackgroundThe structural biology of HIV-1: mechanistic and therapeutic insights
Engelman, A., & Cherepanov, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2747 · Cited by 424
Redefining the Viral Reservoirs that Prevent HIV-1 Eradication
Eisele, E., & Siliciano, R. F. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.010 · Cited by 474
“In addition, the recently identified host restriction factor SAMHD1may protect these cells from infection (Laguette et al., 2011).”
BackgroundSAMHD1 acts at stalled replication forks to prevent interferon induction
Coquel, F., Silva, M.-J., Técher, H., Zadorozhny, K., Sharma, S., Nieminuszczy, J., Mettling, C., Dardillac, E., Barthe, A., Schmitz, A.-L., et al. (2018) · Nature · doi:10.1038/s41586-018-0050-1 · Cited by 442
Self-citationType I interferonopathies: a novel set of inborn errors of immunity
Crow, Y. J. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06220.x · Cited by 404
NEAT1 Long Noncoding RNA and Paraspeckle Bodies Modulate HIV-1 Posttranscriptional Expression
Zhang, Q., Chen, C.-Y., Yedavalli, V. S. R. K., & Jeang, K.-T. (2013) · mBio · doi:10.1128/mbio.00596-12 · Cited by 389
Phosphorylation of SAMHD1 by Cyclin A2/CDK1 Regulates Its Restriction Activity toward HIV-1
Cribier, A., Descours, B., Valadão, A. L. C., Laguette, N., & Benkirane, M. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.017 · Cited by 370
“These cellular factors mediate a cellintrinsic resistance that arrest the viral life cycle at a specific step (Hrecka et al., 2011; Kirchhoff, 2010; Laguette et al., 2011; Malim and Bieniasz, 2012).”
BackgroundSelf-citationLahaye, X., Satoh, T., Gentili, M., Cerboni, S., Conrad, C., Hurbain, I., El Marjou, A., Lacabaratz, C., Lelièvre, J.-D., & Manel, N. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.002 · Cited by 390
“, 2010), which is imposed by the restriction factor SAMHD1 (Hrecka et al., 2011; Laguette et al., 2011), an Aicardi-Goutières Syndrome (AGS) susceptibility gene (Rice et al.”
InfluentialPast, present and future: 30 years of HIV research
Barré-Sinoussi, F., Ross, A. L., & Delfraissy, J.-F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3132 · Cited by 332
Constitutive immune mechanisms: mediators of host defence and immune regulation
Paludan, S. R., Pradeu, T., Masters, S. L., & Mogensen, T. H. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-0391-5 · Cited by 362
Evolutionary conflicts between viruses and restriction factors shape immunity
Duggal, N. K., & Emerman, M. (2012) · Nature Reviews Immunology · doi:10.1038/nri3295 · Cited by 366
“Decreasing its endogenous expression in monocytes using RNA interference enhanced the replication of HIV-1, and exogenously expressing SAMHD1 in terminally differentiated myeloid cells restricted HIV-1 replication 7, 8 .”
BackgroundInfluentialNew frontiers in the cGAS-STING intracellular DNA-sensing pathway
Dvorkin, S., Cambier, S., Volkman, H. E., & Stetson, D. B. (2024) · Immunity · doi:10.1016/j.immuni.2024.02.019 · Cited by 352
Animal models for HIV/AIDS research
Hatziioannou, T., & Evans, D. T. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2911 · Cited by 340
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
Wu, X., Dao Thi, V. L., Huang, Y., Billerbeck, E., Saha, D., Hoffmann, H.-H., Wang, Y., Silva, L. A. V., Sarbanes, S., Sun, T., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.018 · Cited by 385
“However, this high ISG expression phenotype was significantly less pronounced during in vivo differentiation of HSCs. Recently, some studies have shown high expression of certain ISGs in terminally differentiated primary cells (Allen et al., 2017; Laguette et al., 2011).”
Lentiviral vectors: basic to translational
Sakuma, T., Barry, M. A., & Ikeda, Y. (2012) · Biochemical Journal · doi:10.1042/bj20120146 · Cited by 336
SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4+T-cells
Descours, B., Cribier, A., Chable-Bessia, C., Ayinde, D., Rice, G., Crow, Y., Yatim, A., Schwartz, O., Laguette, N., & Benkirane, M. (2012) · Retrovirology · doi:10.1186/1742-4690-9-87 · Cited by 334
“Immunofluorescence Purified CD4 T-cells were stimulated for 3 days with anti-CD3, anti-CD28 and IL-2 and transduced with Vpx expressing retroviral construct [13].”
BackgroundMethodSelf-citationPowell, R. D., Holland, P. J., Hollis, T., & Perrino, F. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c111.317628 · Cited by 344
HIV-1 transcription and latency: an update
Van Lint, C., Bouchat, S., & Marcello, A. (2013) · Retrovirology · doi:10.1186/1742-4690-10-67 · Cited by 338
“ies by the Benkirane’s group and Skowronski’s group, SAMHD1 was recently described as the restriction factor that blocks HIV-1 infection of non-cycling myeloid cells [185,186].”
BackgroundThe role of ubiquitylation in immune defence and pathogen evasion
Jiang, X., & Chen, Z. J. (2012) · Nature Reviews Immunology · doi:10.1038/nri3111 · Cited by 353
Targeting the Latent Reservoir for HIV-1
Sengupta, S., & Siliciano, R. F. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.030 · Cited by 340
“Degradation of dNTPs by host restriction factor SAMHD1 within macrophages slows the reverse transcription process and therefore limits productive infection of macrophages by HIV-1 (Laguette et al., 2011).”
Studies of endogenous retroviruses reveal a continuing evolutionary saga
Stoye, J. P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2783 · Cited by 350
Ochsenbauer, C., Edmonds, T. G., Ding, H., Keele, B. F., Decker, J., Salazar, M. G., Salazar-Gonzalez, J. F., Shattock, R., Haynes, B. F., Shaw, G. M., et al. (2012) · Journal of Virology · doi:10.1128/jvi.06157-11 · Cited by 342
Transmission of innate immune signaling by packaging of cGAMP in viral particles
Gentili, M., Kowal, J., Tkach, M., Satoh, T., Lahaye, X., Conrad, C., Boyron, M., Lombard, B., Durand, S., Kroemer, G., et al. (2015) · Science · doi:10.1126/science.aab3628 · Cited by 320
The enemy within: endogenous retroelements and autoimmune disease
Volkman, H. E., & Stetson, D. B. (2014) · Nature Immunology · doi:10.1038/ni.2872 · Cited by 333
Atkins, J. F., Loughran, G., Bhatt, P. R., Firth, A. E., & Baranov, P. V. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw530 · Cited by 324
“dNTP depletion is part of the hosts response to viral infection and lentiviruses, such as HIV-2, have developed a vpx gene to counteract this effect (100,101).”
BackgroundComparing HIV‐1 and HIV‐2 infection: Lessons for viral immunopathogenesis
Nyamweya, S., Hegedus, A., Jaye, A., Rowland‐Jones, S., Flanagan, K. L., & Macallan, D. C. (2013) · Reviews in Medical Virology · doi:10.1002/rmv.1739 · Cited by 280
White, T. E., Brandariz-Nuñez, A., Valle-Casuso, J. C., Amie, S., Nguyen, L. A., Kim, B., Tuzova, M., & Diaz-Griffero, F. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.03.005 · Cited by 303
“Although the variant HD206AA, which targets the active site of SAMHD1, loses retroviral restriction (Hrecka et al., 2011; Laguette et al., 2011), its oligomerization capacity is also defective, making it difficult to pinpoint which defect causes loss of restriction (White et al.”
BackgroundInfluentialNatural SIV Hosts: Showing AIDS the Door
Chahroudi, A., Bosinger, S. E., Vanderford, T. H., Paiardini, M., & Silvestri, G. (2012) · Science · doi:10.1126/science.1217550 · Cited by 304
“newly described SAMHD1 host restriction factor in myeloid cells (63, 64) and further exploration of the impact of this virus-host interaction, as well as other such interactions --in particular that of BST-2 tetherin with several viral gene products (65)-- is the subject of ongoing research in the natural host field.”
HIV-1 and interferons: who's interfering with whom?
Doyle, T., Goujon, C., & Malim, M. H. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3449 · Cited by 285
The Restriction Factors of Human Immunodeficiency Virus
Harris, R. S., Hultquist, J. F., & Evans, D. T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.416925 · Cited by 287
“Vpx serves as a scaffold for the formation of an E3 ubiquitin ligase complex consisting of DCAF1, DDB1, and CUL4, which combine to promote the polyubiquitination and degradation of SAMHD1 (79, 80, 86).”
BackgroundMacrophages and their relevance in Human Immunodeficiency Virus Type I infection
Koppensteiner, H., Brack-Werner, R., & Schindler, M. (2012) · Retrovirology · doi:10.1186/1742-4690-9-82 · Cited by 280
“In this context it is noteworthy that a recent report investigated the possible connection between SamHD1 polymorphisms in HIV-1 patients and infection and control of the virus.”
BackgroundInfluentialThe ribonuclease activity of SAMHD1 is required for HIV-1 restriction
Ryoo, J., Choi, J., Oh, C., Kim, S., Seo, M., Kim, S.-Y., Seo, D., Kim, J., White, T. E., Brandariz-Nuñez, A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3626 · Cited by 274
Hartmann, G. (2017) · Advances in Immunology · doi:10.1016/bs.ai.2016.11.001 · Cited by 285
“SAMHD1 was identified as a potent restriction factor for HIV (Hrecka et al., 2011; Laguette et al., 2011; Simon, Bloch, & Landau, 2015), other non- human retroviruses (Gramberg et al., 2013), and herpesviruses, including HSV-1 (Hollenbaugh et al., 2013; Kim, White, Brandariz-Nunez, Diaz- Griffero,…”
BackgroundFranzolin, E., Pontarin, G., Rampazzo, C., Miazzi, C., Ferraro, P., Palumbo, E., Reichard, P., & Bianchi, V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312033110 · Cited by 271
“The protein was later renamed SAMHD1 (2) when it was realized that its structure contains two previously known protein modules: an N-terminal short sterile-alpha (SAM) domain (3) and a central longer HD domain (4) with a conserved doublet of histidine (H) and aspartate (D).”
BackgroundIntrinsic host restrictions to HIV-1 and mechanisms of viral escape
Simon, V., Bloch, N., & Landau, N. R. (2015) · Nature Immunology · doi:10.1038/ni.3156 · Cited by 260
Lim, E. S., Fregoso, O. I., McCoy, C. O., Matsen, F. A., Malik, H. S., & Emerman, M. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.01.004 · Cited by 261
“Binding of Diverse Vprs to SAMHD1 Correlates with Degradation Previous studies have shown that Vpx from SIVsm and HIV-2 are able to bind SAMHD1 directly in order to promote its degradation (Hrecka et al., 2011; Laguette et al., 2011).”
InfluentialThe Developmental Control of Transposable Elements and the Evolution of Higher Species
Friedli, M., & Trono, D. (2015) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100814-125514 · Cited by 277
Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response
Wan, D., Jiang, W., & Hao, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00615 · Cited by 270
“This phenomenon has been attributed to the fact that HIV-2 (instead of HIV-1) can encode protein Vpx, which overcomes the SAMHD1 restriction of dNTP in DCs (46, 142) .”
BackgroundInnate immunity against HIV-1 infection
Altfeld, M., & Gale Jr, M. (2015) · Nature Immunology · doi:10.1038/ni.3157 · Cited by 240
Berger, A., Sommer, A. F. R., Zwarg, J., Hamdorf, M., Welzel, K., Esly, N., Panitz, S., Reuter, A., Ramos, I., Jatiani, A., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002425 · Cited by 243
CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses
Descours, B., Petitjean, G., López-Zaragoza, J.-L., Bruel, T., Raffel, R., Psomas, C., Reynes, J., Lacabaratz, C., Levy, Y., Schwartz, O., et al. (2017) · Nature · doi:10.1038/nature21710 · Cited by 242
Self-citationGentili, M., Lahaye, X., Nadalin, F., Nader, G. P. F., Puig Lombardi, E., Herve, S., De Silva, N. S., Rookhuizen, D. C., Zueva, E., Goudot, C., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.105 · Cited by 248
“We next efficiently transduced DCs using Vpx to overcome SAMHD1 restriction (Hrecka et al., 2011; Laguette et al., 2011) (Figure S2A).”
MethodThe HIV Reservoir in Monocytes and Macrophages
Wong, M. E., Jaworowski, A., & Hearps, A. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01435 · Cited by 221
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
Sloas, C., Gill, S., & Klichinsky, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.783305 · Cited by 241
“Upon infection, Vpx mediates degradation of SAMHD1, a myeloid-specific HIV-1 restriction factor that inhibits lentiviral transduction by limiting the deoxynucleotide pool and preventing efficient reverse transcription (79).”
BackgroundIzquierdo-Useros, N., Lorizate, M., Puertas, M. C., Rodriguez-Plata, M. T., Zangger, N., Erikson, E., Pino, M., Erkizia, I., Glass, B., Clotet, B., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001448 · Cited by 244
“In the first approach, we transduced DCs with lentiviral particles coding for different shRNAs by co-infection with vpxexpressing lentiviruses to counteract the restriction factor SAMHD1 and facilitate DC productive infection.”
BackgroundHuman Genetic Determinants of Viral Diseases
Kenney, A. D., Dowdle, J. A., Bozzacco, L., McMichael, T. M., St. Gelais, C., Panfil, A. R., Sun, Y., Schlesinger, L. S., Anderson, M. Z., Green, P. L., et al. (2017) · Annual Review of Genetics · doi:10.1146/annurev-genet-120116-023425 · Cited by 241
Bacterial origins of human cell-autonomous innate immune mechanisms
Wein, T., & Sorek, R. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00705-4 · Cited by 249
Clifford, R., Louis, T., Robbe, P., Ackroyd, S., Burns, A., Timbs, A. T., Wright Colopy, G., Dreau, H., Sigaux, F., Judde, J. G., et al. (2014) · Blood · doi:10.1182/blood-2013-04-490847 · Cited by 230
Self-citationRapid inflammasome activation in microglia contributes to brain disease in HIV/AIDS
Walsh, J. G., Reinke, S. N., Mamik, M. K., McKenzie, B. A., Maingat, F., Branton, W. G., Broadhurst, D. I., & Power, C. (2014) · Retrovirology · doi:10.1186/1742-4690-11-35 · Cited by 231
“Although PMA-differentiated THP-1 cells are not productively infected by HIV-1 due to high expression of SAMDH1, these cells remain permissive to viral infection [46].”
BackgroundBeloglazova, N., Flick, R., Tchigvintsev, A., Brown, G., Popovic, A., Nocek, B., & Yakunin, A. F. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.431148 · Cited by 215
“SAMHD1 also restricts HIV-1 replication by depleting the intracellular dNTP pool and is counteracted by the HIV-2 accessory protein Vpx (4, 5, 21).”
BackgroundInfluentialStealing the Keys to the Kitchen: Viral Manipulation of the Host Cell Metabolic Network
Goodwin, C. M., Xu, S., & Munger, J. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.08.007 · Cited by 226
“Vpx binds and inhibits SAMHD1, resulting in increased dNTP concentrations and restored viral replication [76].”
BackgroundRecognition of nucleic acids by pattern‐recognition receptors and its relevance in autoimmunity
Kawasaki, T., Kawai, T., & Akira, S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01048.x · Cited by 217
HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells
Chavez, L., Calvanese, V., & Verdin, E. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004955 · Cited by 215
“Vpx is a lentiviral accessory protein encoded by HIV-2 that degrades SAMHD1 and thereby allows the virus to infect many cell types—resting CD4 T cells [28], dendritic cells, monocytes, and macrophages [50, 51]—that are usually off limits to Role of T Cell Activation in Establishment of HIV Latency”
BackgroundIntracellular Nucleic Acid Detection in Autoimmunity
Crowl, J. T., Gray, E. E., Pestal, K., Volkman, H. E., & Stetson, D. B. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052331 · Cited by 223
“Two years later, two groups identified SAMHD1 as the essential myeloid restriction factor for HIV-1 that is targeted for degradation by the Vpx accessory protein of HIV-2 (82, 83).”
BackgroundFTSJ3 is an RNA 2′-O-methyltransferase recruited by HIV to avoid innate immune sensing
Ringeard, M., Marchand, V., Decroly, E., Motorin, Y., & Bennasser, Y. (2019) · Nature · doi:10.1038/s41586-018-0841-4 · Cited by 215
Self-citationAPOBEC3A Is a Specific Inhibitor of the Early Phases of HIV-1 Infection in Myeloid Cells
Berger, G., Durand, S., Fargier, G., Nguyen, X.-N., Cordeil, S., Bouaziz, S., Muriaux, D., Darlix, J.-L., & Cimarelli, A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002221 · Cited by 207
PQBP1 Is a Proximal Sensor of the cGAS-Dependent Innate Response to HIV-1
Yoh, S. M., Schneider, M., Seifried, J., Soonthornvacharin, S., Akleh, R. E., Olivieri, K. C., De Jesus, P. D., Ruan, C., de Castro, E., Ruiz, P. A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.050 · Cited by 202
“The experimental models in this report have relied on the introduction of Vpx, which alleviates the block of early reverse transcription at the minus strand strong stop in highly restrictive cells, such as DCs (Hrecka et al., 2011; Laguette et al., 2011).”
Kim, B., Nguyen, L. A., Daddacha, W., & Hollenbaugh, J. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.c112.374843 · Cited by 204
“Vpx promotes the DCAF1 E3 ubiquitin ligase-mediated degradation of SAMHD1 (6, 7).”
BackgroundResultDeoxyribonucleotide metabolism, mutagenesis and cancer
Mathews, C. K. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3981 · Cited by 198
The Role of Macrophages in HIV-1 Persistence and Pathogenesis
Kruize, Z., & Kootstra, N. A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02828 · Cited by 193
“…triphosphates), in turn reducing the dNTPs pool and thereby limiting the reverse transcriptase activity (Berger A. et al., 2011; Hrecka et al., 2011; Laguette et al., 2011; Lahouassa et al., 2012); Myxovirusresistance protein 2 (MX2) which inhibits HIV-1 replication post entry by hindering the…”
BackgroundAhn, J., Hao, C., Yan, J., DeLucia, M., Mehrens, J., Wang, C., Gronenborn, A. M., & Skowronski, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.340711 · Cited by 184
St Gelais, C., de Silva, S., Amie, S. M., Coleman, C. M., Hoy, H., Hollenbaugh, J. A., Kim, B., & Wu, L. (2012) · Retrovirology · doi:10.1186/1742-4690-9-105 · Cited by 191
“Vpxmediated degradation of SAMHD1 accounts for the enhanced HIV-1 infection in myeloid cells [11-13,16].”
BackgroundInfluentialEbola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic
Diehl, W. E., Lin, A. E., Grubaugh, N. D., Carvalho, L. M., Kim, K., Kyawe, P. P., McCauley, S. M., Donnard, E., Kucukural, A., McDonel, P., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.014 · Cited by 195
“For MDDC infec tions, Vpx-containing VLPs were also added to the medium, in order to overcome a SAMHD1 block to viral infection (Laguette et al., 2011).”
BackgroundSAMHD1 Promotes DNA End Resection to Facilitate DNA Repair by Homologous Recombination
Daddacha, W., Koyen, A. E., Bastien, A. J., Head, P. E., Dhere, V. R., Nabeta, G. N., Connolly, E. C., Werner, E., Madden, M. Z., Daly, M. B., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.008 · Cited by 193
“, 2011) with a well-defined role in restricting HIV type 1 (HIV-1) and other viral infections, particularly in non-dividing cells by depleting dNTPs required for reverse transcription and replication (Baldauf et al., 2012; Hrecka et al., 2011; Laguette et al., 2011; Lahouassa et al., 2012).”
BackgroundMethodInfluentialThe importance of monocytes and macrophages in HIV pathogenesis, treatment, and cure
Campbell, J. H., Hearps, A. C., Martin, G. E., Williams, K. C., & Crowe, S. M. (2014) · AIDS · doi:10.1097/qad.0000000000000408 · Cited by 187
“By inducing proteasomal degradation of the host restriction factor SAMHD1, Vpx increases monocyte and macrophage susceptibility to SIV infection [26].”
BackgroundInfluentialModulation of LINE-1 and Alu/SVA Retrotransposition by Aicardi-Goutières Syndrome-Related SAMHD1
Zhao, K., Du, J., Han, X., Goodier, J. L., Li, P., Zhou, X., Wei, W., Evans, S. L., Li, L., Zhang, W., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.019 · Cited by 194
“SAMHD1 restricts the retroviral reverse transcription in nondividing myeloid cells by depleting the intracellular dNTP pool (Berger et al., 2011; Goldstone et al., 2011; Hrecka et al., 2011; Laguette et al., 2011; Lahouassa et al., 2012; Powell et al., 2011).”
InfluentialType I interferonopathies: Mendelian type I interferon up-regulation
Crow, Y. J. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.10.005 · Cited by 190
Molecular insights into NF2/Merlin tumor suppressor function
Cooper, J., & Giancotti, F. G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.001 · Cited by 191
Sze, A., Belgnaoui, S. M., Olagnier, D., Lin, R., Hiscott, J., & van Grevenynghe, J. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.09.009 · Cited by 182
“Human myeloid and bystander CD4 T cells are refractory to HIV-1 infection, in part because the host restriction factor SAMHD1 prevents efficient viral DNA synthesis (Baldauf et al., 2012; Descours et al., 2012; Laguette and Benkirane, 2012; Laguette et al., 2011).”
InfluentialImmune Sensing Mechanisms that Discriminate Self from Altered Self and Foreign Nucleic Acids
Bartok, E., & Hartmann, G. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.014 · Cited by 182
Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1
Colomer-Lluch, M., Ruiz, A., Moris, A., & Prado, J. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02876 · Cited by 167
“Owing to the inefficient capacity of HIV-1 to infect DCs, mainly due to the restriction exerted by SAMHD1, it has been proposed that HIV-1 might evade innate sensing (4, 77).”
BackgroundInfluentialDolan, M.-J., Therrien, M., Jereb, S., Kamath, T., Gazestani, V., Atkeson, T., Marsh, S. E., Goeva, A., Lojek, N. M., Murphy, S., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01558-2 · Cited by 185
“Transduction of monocytes with lentiviruses is facilitated by the SIV-encoded protein Vpx 38,39 , which degrades SAMHD1, a restriction factor that prevents reverse transcription of lentiviral RNA 40,41 .”
BackgroundLaguette, N., Rahm, N., Sobhian, B., Chable-Bessia, C., Münch, J., Snoeck, J., Sauter, D., Switzer, W. M., Heneine, W., Kirchhoff, F., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.01.007 · Cited by 174
Self-citationIFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein
Yu, J., Li, M., Wilkins, J., Ding, S., Swartz, T. H., Esposito, A. M., Zheng, Y.-M., Freed, E. O., Liang, C., Chen, B. K., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.055 · Cited by 170
“Among these, APOBEC3G, TRIM5a, Tetherin or Bst2, SAMHD1, and MxB have been reported as potent anti-HIV restriction factors (Goujon et al., 2013; Hrecka et al., 2011; Kane et al., 2013; Laguette et al., 2011; Liu et al., 2013; Neil et al., 2008; Sadler and Williams, 2008; Sheehy et al., 2002; Stremlau et al., 2004; Van…”
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
Schneider, C., Oellerich, T., Baldauf, H.-M., Schwarz, S.-M., Thomas, D., Flick, R., Bohnenberger, H., Kaderali, L., Stegmann, L., Cremer, A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4255 · Cited by 177
Puryear, W. B., Akiyama, H., Geer, S. D., Ramirez, N. P., Yu, X., Reinhard, B. M., & Gummuluru, S. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003291 · Cited by 181
“In addition to the observation that HIV-1 fusion to DCs dramatically declines upon maturation [61], intracellular environment of DCs is antagonistic to productive virus replication, presumably because of presence of SAMHD1 and other yet-to-be defined IFN-induced myeloid cell-specific antiviral factors [62,63,64,65].”
BackgroundTarget-Selective Protein S-Nitrosylation by Sequence Motif Recognition
Jia, J., Arif, A., Terenzi, F., Willard, B., Plow, E. F., Hazen, S. L., & Fox, P. L. (2014) · Cell · doi:10.1016/j.cell.2014.09.032 · Cited by 176
Macrophages and HIV-1: An Unhealthy Constellation
Sattentau, Q. J., & Stevenson, M. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.02.013 · Cited by 167
“SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase that reduces cellular dNTPs to a level that is unfavorable for viral reverse transcription.”
BackgroundInfluentialA Critical Balance: dNTPs and the Maintenance of Genome Stability
Pai, C., & Kearsey, S. (2017) · Genes · doi:10.3390/genes8020057 · Cited by 158
Mechanism of allosteric activation of SAMHD1 by dGTP
Ji, X., Wu, Y., Yan, J., Mehrens, J., Yang, H., DeLucia, M., Hao, C., Gronenborn, A. M., Skowronski, J., Ahn, J., et al. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2692 · Cited by 161
Sumida, T. S., Dulberg, S., Schupp, J. C., Lincoln, M. R., Stillwell, H. A., Axisa, P.-P., Comi, M., Unterman, A., Kaminski, N., Madi, A., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01152-y · Cited by 164
“For human primary T cells gene knockdown, we adopted lentiviral delivery of shRNAs with lentiviral gene product X (Vpx) containing virus-like particles (VLPs) to efficiently transduce lentivirus into unstimulated primary human naïve T cells 28, 29 (Figure 3b).”
Paleovirology and virally derived immunity
Aswad, A., & Katzourakis, A. (2012) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2012.07.007 · Cited by 170
Locatelli, S., & Peeters, M. (2012) · AIDS · doi:10.1097/qad.0b013e328350fb68 · Cited by 184
SAMHD1 prevents autoimmunity by maintaining genome stability
Kretschmer, S., Wolf, C., König, N., Staroske, W., Guck, J., Häusler, M., Luksch, H., Nguyen, L. A., Kim, B., Alexopoulou, D., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204845 · Cited by 151
Welbourn, S., Dutta, S. M., Semmes, O. J., & Strebel, K. (2013) · Journal of Virology · doi:10.1128/jvi.01642-13 · Cited by 161
“In susceptible cell types, SAMHD1 has been shown to restrict infection of these lentiviruses at the reverse transcription step, and Vpx counteracts this restriction by binding to and causing the proteasomal degradation of SAMHD1 via interaction with a Cul4/DDB1/DCAF1 ubiquitin-ligase complex (2, 3, 11).”
BackgroundBehrendt, R., Schumann, T., Gerbaulet, A., Nguyen, L. A., Schubert, N., Alexopoulou, D., Berka, U., Lienenklaus, S., Peschke, K., Gibbert, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.037 · Cited by 154
“The Vpx accessory protein of many SIV strains and HIV-2 counteracts this restriction by targeting SAMHD1 for proteasomal degradation (Hrecka et al., 2011; Laguette et al., 2011).”
Influential
Metadata
- Authors
- Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Laguette, Nadine
- Benkirane, Monsef
- ORCID
- Venue
- Nature
- Published
- 2011-05-25
- Volume
- 474
- Issue
- 7353
- Pages
- 654-657
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3595993
- OpenAlex
- W2069554621
- Cited by
- 1,511
- References
- 27
- Citations by year
- 2026: 45 · 2025: 60 · 2024: 67 · 2023: 67 · 2022: 84 · 2021: 72 · 2020: 82 · 2019: 113 · 2018: 113 · 2017: 109 · 2016: 114 · 2015: 118 · 2014: 134 · 2013: 159 · 2012: 131
- FWCI
- 58.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- SAMHD1, HIV-1 restriction factors, Vpx, dendritic cells, myeloid cells, Aicardi-Goutières syndrome, proteasomal degradation, HIV-1 replication, viral DNA accumulation, phosphohydrolase activity, interferon response, HIV-2, simian immunodeficiency virus
- MeSH terms
- SAM Domain and HD Domain-Containing Protein 1, Cell Line, Dendritic Cells, DNA, Viral, HeLa Cells, Humans, Virus Replication, HIV-1, HIV Infections, U937 Cells, Monomeric GTP-Binding Proteins, Gene Silencing, Myeloid Cells, Proteasome Endopeptidase Complex, Viral Regulatory and Accessory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.